BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 22347798)

  • 21. Neuroinflammation and cytokine abnormality in major depression: Cause or consequence in that illness?
    Jeon SW; Kim YK
    World J Psychiatry; 2016 Sep; 6(3):283-93. PubMed ID: 27679767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse testing methods in psychoneuroimmunology: an overview of how to measure sickness, depressive/anxietal, cognitive, and physical activity behaviors.
    York JM; Blevins NA; Baynard T; Freund GG
    Methods Mol Biol; 2012; 934():243-76. PubMed ID: 22933150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant treatment for depression: total charges and therapy duration*.
    Dobrez DG; Melfi CA; Croghan TW; Kniesner TJ; Obenchain RL
    J Ment Health Policy Econ; 2000 Dec; 3(4):187-197. PubMed ID: 11967455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronobiological theories of mood disorder.
    Zaki NFW; Spence DW; BaHammam AS; Pandi-Perumal SR; Cardinali DP; Brown GM
    Eur Arch Psychiatry Clin Neurosci; 2018 Mar; 268(2):107-118. PubMed ID: 28894915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Circadian rhythms and depression].
    Soria V; Urretavizcaya M
    Actas Esp Psiquiatr; 2009; 37(4):222-32. PubMed ID: 19927234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parallel Changes in Mood and Melatonin Rhythm Following an Adjunctive Multimodal Chronobiological Intervention With Agomelatine in People With Depression: A Proof of Concept Open Label Study.
    Robillard R; Carpenter JS; Feilds KL; Hermens DF; White D; Naismith SL; Bartlett D; Whitwell B; Southan J; Scott EM; Hickie IB
    Front Psychiatry; 2018; 9():624. PubMed ID: 30618853
    [No Abstract]   [Full Text] [Related]  

  • 27. [Depression and neuroplasticity. Interaction of nervous, endocrine and immune systems].
    Cassano P; Argibay P
    Medicina (B Aires); 2010; 70(2):185-93. PubMed ID: 20447905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biological models of depression: effect of antidepressants on sleep].
    Viot-Blanc V
    Encephale; 1995 Dec; 21 Spec No 7():35-40. PubMed ID: 8929677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokines as mediators of depression: what can we learn from animal studies?
    Dunn AJ; Swiergiel AH; de Beaurepaire R
    Neurosci Biobehav Rev; 2005; 29(4-5):891-909. PubMed ID: 15885777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does neuroimmune dysfunction mediate seasonal mood changes in winter depression?
    Lam RW; Song C; Yatham LN
    Med Hypotheses; 2004; 63(4):567-73. PubMed ID: 15324998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality.
    Souêtre E; Salvati E; Belugou JL; Pringuey D; Candito M; Krebs B; Ardisson JL; Darcourt G
    Psychiatry Res; 1989 Jun; 28(3):263-78. PubMed ID: 2762432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant drugs and cytokines in mood disorders.
    Nishida A; Hisaoka K; Zensho H; Uchitomi Y; Morinobu S; Yamawaki S
    Int Immunopharmacol; 2002 Nov; 2(12):1619-26. PubMed ID: 12469936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse Testing Methods in Psychoneuroimmunology 2.0: Measuring Behavioral Responses.
    Towers AE; York JM; Baynard T; Gainey SJ; Freund GG
    Methods Mol Biol; 2018; 1781():221-258. PubMed ID: 29705851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant-like effects of melatonin in the mouse chronic mild stress model.
    Detanico BC; Piato AL; Freitas JJ; Lhullier FL; Hidalgo MP; Caumo W; Elisabetsky E
    Eur J Pharmacol; 2009 Apr; 607(1-3):121-5. PubMed ID: 19249298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limitations of current medical treatments for depression: disturbed circadian rhythms as a possible therapeutic target.
    Lader M
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):743-55. PubMed ID: 17624740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian rhythms and treatment implications in depression.
    Monteleone P; Martiadis V; Maj M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1569-74. PubMed ID: 20691746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depression, circadian rhythms and trimipramine.
    Rüther E
    Drugs; 1989; 38 Suppl 1():1-3; discussion 49-50. PubMed ID: 2693050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood-based immune-endocrine biomarkers of treatment response in depression.
    Chan MK; Cooper JD; Bot M; Birkenhager TK; Bergink V; Drexhage HA; Steiner J; Rothermundt M; Penninx BW; Bahn S
    J Psychiatr Res; 2016 Dec; 83():249-259. PubMed ID: 27693950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of neuro-immunological factors in the pathophysiology of mood disorders.
    Bhattacharya A; Derecki NC; Lovenberg TW; Drevets WC
    Psychopharmacology (Berl); 2016 May; 233(9):1623-36. PubMed ID: 26803500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immune system, depression and the action of antidepressants.
    Leonard BE
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 May; 25(4):767-80. PubMed ID: 11383977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.